West Ashley, SC
Goose Creek, SC
Mt. Pleasant, SC
Chadds Ford, Pennsylvania
St. Clair Shores, MI
Myrtle Beach, SC
Location: Atlanta, Georgia
Internal Number: 80644
The Aflac Cancer and Blood Disorders Center of Childrens Healthcare of Atlanta, Emory University School of Medicine and Morehouse School of Medicine are partnering in a $16M expansion of its Sickle Cell Disease Program, supported by an award from the Georgia Research Alliance, and investments from Childrens Healthcare of Atlanta, Emory University, and Morehouse School of Medicine. This initiative will focus on therapeutic development in sickle cell disease and includes the addition of three faculty members at Emory and one at Morehouse School of Medicine. The Aflac Cancer and Blood Disorders Center of Childrens Healthcare of Atlanta, the Emory University Department of Pediatrics and Morehouse School of Medicine invites qualified applicants to apply for the keystone position of this initiative as Director of the Sickle Cell Disease Program.
This position offers a wealth of opportunities for research collaborations within the Department of Pediatrics, Winship Cancer Institute, Grady Hospital as well as with Emory basic science departments, the Rollins School of Public Health, the Georgia Institute of Technology, Morehouse School of Medicine and the Centers for Disease Control and Prevention.
Job Duties and Responsibilities
Provide unifying leadership for the clinical and research components of the Sickle Cell Disease Program of the Aflac Cancer and Blood Disorder Center. Coordinate basic, translational and clinical research efforts in sickle cell disease, with the goal of expanding the availability and utilization of existing treatments and developing new therapeutic approaches. Coordinate clinical care across the three campuses of the program at Scottish Rite, Egleston, and Hughes Spalding Hospitals in partnership with the Sickle Cell Disease Clinical Director. Provide academic leadership and professional mentorship for approximately 16 faculty focused on sickle cell disease. Lead an integrated city-wide Atlanta Sickle Cell Disease Consortium and expand and strengthen collaborations with investigators from other divisions and departments at Emory, Georgia Tech, Georgia State and the Morehouse School of Medicine, with the goal of building a nationally pre-eminent sickle cell disease program. Conduct state-of-the-art research in sickle cell disease. Set an example of excellence, compassion, and cultural sensitivity in clinical care for sickle cell disease. Participate in the leadership of the Aflac Cancer and Blood Disorders Center by serving on the Aflac Executive Committee. Represent the Aflac Sickle Cell Disease Program within Emory and Childrens, to the Atlanta community and at the national/international level. Will have an appointment with Morehouse School of Medicine
Candidates should hold current appointments at the Associate Professor or Professor level. Successful candidates will have: MD or MD/PhD degrees Board Certification in Pediatric Hematology-Oncology Currently licensed as a physician and eligible for licensure as a physician in the State of Georgia Qualifications for appointment as professor at Emory University and Morehouse School of Medicine National recognition in Sickle Cell Disease research (either as a clinical, outcomes, or implementation science researcher or as a translational researcher) A strong record of academic excellence/achievement and funding as an independent investigator A history of academic excellence/achievement A record of mentorship of faculty to support growth in research and scholarship Experience in service or leadership in a hematology-oncology program
Salary and rank of Professor at the Emory University School of Medicine and Morehouse School of Medicine will be commensurate with experience and accomplishment. This position will be expected to engage in clinical service and mentorship of junior faculty and will have dedicated time for administrative duties.
Childrens Healthcare of Atlanta and Emory University have worked together since 1956, facilitating leading-edge pediatric research, training, and innovation. Together, our partnership advances research and facilitates evidence-based quality care for children. In 2020, the Emory Department of Pediatrics was the #1 ranked pediatric department in National Institutes of Health research funding. This position will have an appointment at Emory, Childrens and Morehouse School of Medicine and will help strengthen the relationship between Childrens and Morehouse School of Medicine.
This job posting is part of our ambitious $200M investment to substantially grow our team of world class child health researchers over the next five years. Contact email@example.com for more information.
Applicants interested in this position should apply online and upload a curriculum vitae, a summary of research accomplishments and a description of future independent research plans.
About Our Program
The Aflac Cancer and Blood Disorders Center provides a rich and collaborative environment for basic, clinical and translational research and boasts a diverse faculty. Our Sickle Cell Disease Program is an integral component of the largest pediatric non-malignant hematology program in the nation. Our Sickle Cell Disease Program:
Represents the largest comprehensive pediatric sickle cell disease (SCD) program in the country, providing comprehensive multi-disciplinary outpatient, emergency, and inpatient services for more than 2,000 children and adolescents at three locations in metropolitan Atlanta. Features 17 faculty members, 5 of whom are primarily basic research-focused, and 8 Advanced Practice Providers Program Director position will be supported by the Calvin Smyre GRA Eminent Scholar Endowed Chair. In addition, 3 other members of the program are supported by endowed Chairs. Supports clinical investigators and clinic trials through the Aflac Clinical Research Office which provides regulatory and grants management services and includes a dedicated team of 8 SCD research coordinators who implement outpatient and inpatient studies on all three campuses. Is a leader in the development of curative therapies for SCD in close partnership with our BMT and Gene Therapy Programs. To date we have cured more than 116 children with stem cell transplants and enrolled 7 subjects on national gene therapy trials for SCD. Maintains a clinical database that contains SCD genotype, treatment, and clinical care utilization data on 3,940 unique patients with SCD seen from 2010-2020 providing a valuable resource for program management, quality improvement and health services and outcomes research Is a leader in multi-center clinical trials in sickle cell disease. Is the leader of the Atlanta Sickle Cell Disease Consortiuma citywide collaboration of physicians and researchers from Emory, Morehouse School of Medicine, Georgia Institute of Technology, and Georgia State University, advancing the treatment of sickle cell disease and developing curative therapies.
About the Aflac Cancer and Blood Disorders Center The successful candidate will join one of the strongest pediatric hematology/oncology programs in the country. Our Center has 115 faculty and 35 Advance Practice Providers (APPs), conducting basic, translational, and clinical research in gene therapy, focusing on CAR T-cell therapies, hemoglobinopathies, and hemophilia. More than 7,000 children with cancer and blood disorders are treated annually at the Aflac Cancer and Blood Disorders Center The Aflac pediatric hematology program is one of the largest in the country (including over 2,000 active patients with sickle cell disease, and 600 with bleeding or clotting disorders) The Aflac blood and marrow transplantation program performed over 80 transplants last year, and having performed over 100 transplants in sickle cell disease, is one of the leaders in curative therapies for hemoglobinopathies. In 2021, we were ranked No. 6 in the nation by US News and World Report for Pediatric Cancer In 2020, our faculty generated $21.5M in extramural funding including more than $12.3M from the NIH Our pediatric oncology program cared for more than 500 new cancer cases last year and is the pediatric component of the Winship Cancer Institute of Emory University. Our fellowship program accepts 6 fellows each year for intensive clinical and research training in pediatric hematology/oncology. We are one of the few pediatric programs with an NIH-funded T32 training grant in non-malignant hematology
About the Emory Department of Pediatrics We have over 450 faculty members, including 121 PhD faculty, and 156 faculty with extramural research funding. We rank 1st nationally among Pediatric Departments in NIH funding, with more than $97M in 2020. In addition to Aflac, basic science research programs exist in cystic fibrosis, immunology, virology and vaccine development, gastroenterology and hepatology, cardiology, and biomedical engineering. Our laboratories train more PhD students than any other Emory department. Department of Pediatrics is centrally located in two main facilities: Health Sciences Research Building (HSRB) with 115,000 GSF dedicated to research and the Emory-Childrens Center (ECC) which includes 64,500 sq. ft. of research space and a 12,500 sq. ft. small animal vivarium. The new HSRB II Building is expected to open April 2022, which will add an additional 350,000 sq. ft. of research space.
About Childrens Healthcare of Atlanta As the only tertiary pediatric center in the dynamic metropolitan Atlanta area, serving a population of over 6 million people, Childrens provides a rich environment for clinical programs in rare disorders. With 638 beds on 3 campuses, Childrens is a national volume leader in Hematology, Cardiology, Surgery, Orthopedics, and Emergency Medicine. Childrens has embarked on a $2.2 B expansion, including a new 1.25 M sq. ft. hospital complex to be completed in 2025, bringing total beds to 758.
Employment will be in the Emory + Children's Pediatric Institute. The Emory + Childrens Pediatric Institute is an affiliation between Emory University and Childrens Healthcare of Atlanta that is improving the lives of children in Georgia and beyond. The Pediatric Institute combines the unique strengths and resources of each institution in support of our three-part academic missions of providing outstanding clinical care, conducting innovative basic science discovery and clinical research, and coordinating exceptional education of the future healthcare workforce.
Our physicians, researchers, and educators have created a model where leadership, commitment and quality are fundamental components of success. Together, we are transforming pediatrics by achieving new levels of clinical excellencedriven by research, teaching and wellness. We look forward to our future together.